Sabine Reiter: Poliomyelitis. In: Heinz Spiess, Ulrich Heininger, Wolfgang Jilg (Hrsg.): Impfkompendium. 8. Auflage. Georg Thieme Verlag, 2015, ISBN 978-3-13-498908-3, S.257, doi:10.1055/b-0035-127596.
T. Jacob John: Role of injectable and oral polio vaccines in polio eradication, doi:10.1586/14760584.8.1.5
Matthew R. Behrend et al.: A quantitative survey of the literature on poliovirus infection and immunity. In: International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases. Band18, Januar 2014, S.4–13, doi:10.1016/j.ijid.2013.09.005, PMID 24246740.
Olen M. Kew et al.: Vaccine-derived polioviruses and the endgame strategy for global polio eradication. In: Annual Review of Microbiology. Band59, 2005, S.587–635, doi:10.1146/annurev.micro.58.030603.123625, PMID 16153180.
Nidia H. De Jesus: Epidemics to eradication: the modern history of poliomyelitis. In: Virology Journal. Band4, 10. Juli 2007, S.70, doi:10.1186/1743-422X-4-70, PMID 17623069, PMC 1947962 (freier Volltext).
Nicholas C. Grassly et al.: Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study. In: Lancet (London, England). Band369, Nr.9570, 21. April 2007, S.1356–1362, doi:10.1016/S0140-6736(07)60531-5, PMID 17448821.
Joseph Kl Opare et al.: Poliovirus neutralizing antibody levels among individuals in three regions of Ghana. In: Ghana Medical Journal. Band53, Nr.2, Juni 2019, S.170–180, doi:10.4314/gmj.v53i2.13, PMID 31481814, PMC 6697761 (freier Volltext).
Lauren R. Platt et al.: Vaccine-Associated Paralytic Poliomyelitis: A Review of the Epidemiology and Estimation of the Global Burden. In: The Journal of Infectious Diseases. Band210, suppl_1, 1. November 2014, S.S380–S389, doi:10.1093/infdis/jiu184.
F. Graham: Daily briefing: Polio outbreaks in New York, London and Jerusalem. In: Nature. [elektronische Veröffentlichung vor dem Druck] August 2022, doi:10.1038/d41586-022-02306-6, PMID 35999363.
A. S. Bandyopadhyay, S. Zipursky: A novel tool to eradicate an ancient scourge: the novel oral polio vaccine type 2 story. In: The Lancet. Infectious diseases. [elektronische Veröffentlichung vor dem Druck] September 2022, doi:10.1016/S1473-3099(22)00582-5, PMID 36162417.
Paul A. Offit: The Cutter incident, 50 years later. In: The New England Journal of Medicine. Band352, Nr.14, 7. April 2005, S.1411–1412, doi:10.1056/NEJMp048180, PMID 15814877.
Danielle L. Poulin und James A. DeCaprio: Is there a role for SV40 in human cancer? In: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. Band24, Nr.26, 10. September 2006, S.4356–4365, doi:10.1200/JCO.2005.03.7101, PMID 16963733.
Matthew R. Behrend et al.: A quantitative survey of the literature on poliovirus infection and immunity. In: International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases. Band18, Januar 2014, S.4–13, doi:10.1016/j.ijid.2013.09.005, PMID 24246740.
Olen M. Kew et al.: Vaccine-derived polioviruses and the endgame strategy for global polio eradication. In: Annual Review of Microbiology. Band59, 2005, S.587–635, doi:10.1146/annurev.micro.58.030603.123625, PMID 16153180.
Nidia H. De Jesus: Epidemics to eradication: the modern history of poliomyelitis. In: Virology Journal. Band4, 10. Juli 2007, S.70, doi:10.1186/1743-422X-4-70, PMID 17623069, PMC 1947962 (freier Volltext).
Eugenia Dragunsky et al.: Transgenic mice as an alternative to monkeys for neurovirulence testing of live oral poliovirus vaccine: validation by a WHO collaborative study. In: Bulletin of the World Health Organization. Band81, Nr.4, 2003, S.251–260, PMID 12764491, PMC 2572431 (freier Volltext).
Nicholas C. Grassly et al.: Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study. In: Lancet (London, England). Band369, Nr.9570, 21. April 2007, S.1356–1362, doi:10.1016/S0140-6736(07)60531-5, PMID 17448821.
Joseph Kl Opare et al.: Poliovirus neutralizing antibody levels among individuals in three regions of Ghana. In: Ghana Medical Journal. Band53, Nr.2, Juni 2019, S.170–180, doi:10.4314/gmj.v53i2.13, PMID 31481814, PMC 6697761 (freier Volltext).
Vaccine-derived poliomyelitis in Nigeria. In: Lancet. 2007 Oct 20;370(9596), S. 1394, PMID 17950846.
F. Graham: Daily briefing: Polio outbreaks in New York, London and Jerusalem. In: Nature. [elektronische Veröffentlichung vor dem Druck] August 2022, doi:10.1038/d41586-022-02306-6, PMID 35999363.
A. S. Bandyopadhyay, S. Zipursky: A novel tool to eradicate an ancient scourge: the novel oral polio vaccine type 2 story. In: The Lancet. Infectious diseases. [elektronische Veröffentlichung vor dem Druck] September 2022, doi:10.1016/S1473-3099(22)00582-5, PMID 36162417.
Paul A. Offit: The Cutter incident, 50 years later. In: The New England Journal of Medicine. Band352, Nr.14, 7. April 2005, S.1411–1412, doi:10.1056/NEJMp048180, PMID 15814877.
Danielle L. Poulin und James A. DeCaprio: Is there a role for SV40 in human cancer? In: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. Band24, Nr.26, 10. September 2006, S.4356–4365, doi:10.1200/JCO.2005.03.7101, PMID 16963733.
Centers for Disease Control and Prevention (CDC): Progress toward interruption of wild poliovirus transmission--worldwide, January 2007-April 2008. In: MMWR. Morbidity and mortality weekly report. Band57, Nr.18, 9. Mai 2008, S.489–494, PMID 18463607.